Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Jun 6;282(6279):1826–1829. doi: 10.1136/bmj.282.6279.1826

Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute non-lymphocytic leukaemia.

L Skoog, B Nordenskjöld, A Ost, B Andersson, R Hast, N Giannoulis, S Humla, T Hägerström, P Reizenstein
PMCID: PMC1506447  PMID: 6263401

Abstract

Activity of terminal deoxynucleotidyl transferase (TdT), adenosine deaminase, and 5'nucleotidase and the cellular concentration of glucocorticoid (dexamethasone) receptor were determined in 25 patients with acute non-lymphocytic leukaemia. All patients were treated according to a common protocol. Increased activity of TdT (greater than 0.1 unit/microgram DNA) was found in 11 patients. This group of patients was shown to have higher remission and survival rates (p = 0.06) compared with patients with low activity of TdT. The glucocorticoid receptor concentration of the leukaemic blast cells ranged from 0 to 0.94 fmol/microgram DNA. Thirteen patients had blast cells with a glucocorticoid receptor concentration over 0.22 fmol/microgram DNA. These patients had significantly increased remission and survival rates (p = 0.006) compared with those with a low receptor concentration. This finding cannot be explained by a difference in sensitivity to glucocorticoids since these were not used as therapeutic agents. Adenosine deaminase and 5'nucleotidase activities both varied within two orders of magnitude. No correlation could be found between activities of these enzymes and remission or survival rate. These results show that measurements of TdT activity and the glucocorticoid receptor concentration yield valuable prognostic information in acute non-lymphocytic leukaemia.

Full text

PDF
1826

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  3. Ellis R. B., Rapson N. T., Patrick A. D., Greaves M. F. Expression of hexosaminidase isoenzymes in childhood leukemia. N Engl J Med. 1978 Mar 2;298(9):476–480. doi: 10.1056/NEJM197803022980902. [DOI] [PubMed] [Google Scholar]
  4. FISCHER R., SCHMALZL F. UBER DIE HEMMBARKEIT DER ESTERASEAKTIVITAET IN BLUTMONOCYTEN DURCH NATRIUMFLUORID. Klin Wochenschr. 1964 Aug 1;42:751–751. doi: 10.1007/BF01487816. [DOI] [PubMed] [Google Scholar]
  5. Hoffbrand A. V., Ganeshaguru K., Janossy G., Greaves M. F., Catovsky D., Woodruff R. K. Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet. 1977 Sep 10;2(8037):520–523. doi: 10.1016/s0140-6736(77)90662-6. [DOI] [PubMed] [Google Scholar]
  6. Kaplow I. S. Letter: Substitute for benzidine in myeloperoxidase stains. Am J Clin Pathol. 1975 Mar;63(3):451–451. doi: 10.1093/ajcp/63.3.451. [DOI] [PubMed] [Google Scholar]
  7. LOEFFLER H. [Cytochemical proof of nonspecific esterase in smears. Contributions on the technic and findings in human blood smears]. Klin Wochenschr. 1961 Dec 1;39:1220–1227. doi: 10.1007/BF01506146. [DOI] [PubMed] [Google Scholar]
  8. Lippman M. E., Halterman R. H., Leventhal B. G., Perry S., Thompson E. B. Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J Clin Invest. 1973 Jul;52(7):1715–1725. doi: 10.1172/JCI107353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MOLONEY W. C., MCPHERSON K., FLIEGELMAN L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem. 1960 May;8:200–207. doi: 10.1177/8.3.200. [DOI] [PubMed] [Google Scholar]
  10. Marcus S. L., Smith S. W., Jarowski C. I., Modak M. J. Terminal deoxyribonucleotidyl transferase activity in acute undifferentiated leukemia. Biochem Biophys Res Commun. 1976 May 3;70(1):37–44. doi: 10.1016/0006-291x(76)91105-0. [DOI] [PubMed] [Google Scholar]
  11. Marks S. M., Baltimore D., McCaffrey R. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study. N Engl J Med. 1978 Apr 13;298(15):812–814. doi: 10.1056/NEJM197804132981503. [DOI] [PubMed] [Google Scholar]
  12. Meier J., Coleman M. S., Hutton J. J. Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies. Br J Cancer. 1976 Mar;33(3):312–319. doi: 10.1038/bjc.1976.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mertelsmann R., Koziner B., Ralph R., Filippa D., McKenzie S., Arlin Z. A., Gee T. S., Moore M. A., Clarkson B. D. Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia. Blood. 1978 Jun;51(6):1051–1056. [PubMed] [Google Scholar]
  14. Quagliata F., Faig D., Conklyn M., Silber R. Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells. Cancer Res. 1974 Dec;34(12):3197–3202. [PubMed] [Google Scholar]
  15. Yarbro G. S., Lippman M. E., Johnson G. E., Leventhal B. G. Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia. Cancer Res. 1977 Aug;37(8 Pt 1):2688–2695. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES